Process for producing antibiotic nanaomycin E
    9.
    发明授权
    Process for producing antibiotic nanaomycin E 失效
    生产抗生素纳米霉素E的方法

    公开(公告)号:US4353986A

    公开(公告)日:1982-10-12

    申请号:US276432

    申请日:1981-06-22

    摘要: The present invention teaches a new antibiotic nanaomycin E represented by the formula: ##STR1## Nanaomycin E is active against Gram-positive bacteria, Trichophyton and Mycoplasma and may be used as antibacterial and therapeutic agents for humans and animals. Nanaomycin E is also a useful starting material for the preparation of nanaomycin A which latter nanaomycin has the highest activity among the various nanaomycin-type compounds. Nanaomycin E is produced by fermentation of a microorganism belonging to the genus Streptomyces and capable of producing nanaomycin E, especially Streptomyces rosa variant notoensis (FERM-P 2209; ATCC 31135) and recovering the same from the fermented liquor.

    摘要翻译: 本发明教导了由下式表示的新型抗生素纳那霉素E:Nanaomycin E对革兰氏阳性菌,毛癣菌和支原体具有活性,可用作人和动物的抗菌剂和治疗剂。 纳那霉素E也是制备纳诺霉素A的有用起始原料,后者纳那霉素在各种纳诺霉素型化合物中具有最高的活性。 纳豆霉素E是通过发酵属于链霉菌属的微生物产生的,并且能够产生纳诺霉素E,特别是罗氏不动杆菌(FERM-P 2209; ATCC 31135),并从发酵液中回收。